{
    "Disease activity (follow up: 3 months; assessed with: ACR 20)": {
        "No of studies": "2",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["serious", "b"],
        "Other considerations": "none",
        "Nº of patients": {
            "Switch to TNFi": "19/53 (35.8%)",
            "Switch to JAKi": "29/49 (59.2%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 0.61 (0.39 to 0.93)",
            "Absolute (95% CI)": "231 fewer per 1,000 (from 361 fewer to 41 fewer)"
        },
        "Certainty": "⨁⨁◯◯ LOW",
        "Importance": "CRITICAL"
    },

    "Disease activity (follow up: 3 months; assessed with: ACR 50)": {
        "No of studies": "2",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious", "c"],
        "Other considerations": "none",
        "Nº of patients": {
            "Switch to TNFi": "10/53 (18.9%)",
            "Switch to JAKi": "17/49 (34.7%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 0.54 (0.28 to 1.07)",
            "Absolute (95% CI)": "160 fewer per 1,000 (from 250 fewer to 24 more)"
        },
        "Certainty": "⨁◯◯◯ VERY LOW",
        "Importance": "CRITICAL"
    },

    "Disease activity (follow up: 3 months; assessed with: ACR 70)": {
        "No of studies": "2",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["very serious", "c"],
        "Other considerations": "none",
        "Nº of patients": {
            "Switch to TNFi": "2/53 (3.8%)",
            "Switch to JAKi": "6/49 (12.2%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 0.31 (0.07 to 1.46)",
            "Absolute (95% CI)": "84 fewer per 1,000 (from 114 fewer to 56 more)"
        },
        "Certainty": "⨁◯◯◯ VERY LOW",
        "Importance": "CRITICAL"
    },

    "Disability (follow up: 3 months; assessed with: HAQ-DI (Lower values – > benefit) (MCID -0.22)": {
        "No of studies": "2",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["serious", "b"],
        "Other considerations": "none",
        "Nº of patients": {
            "Switch to TNFi": "49",
            "Switch to JAKi": "53"
        },
        "Effect": {
            "Relative (95% CI)": "-",
            "Absolute (95% CI)": "MD 0.16 higher (0.13 higher to 0.19 higher)"
        },
        "Certainty": "⨁⨁◯◯ LOW",
        "Importance": "IMPORTANT"
    },

    "Pain (follow up: 3 months; assessed with: VAS 0-100 (Lower values – > benefit) (MCID -11.9)": {
        "No of studies": "2",
        "Study design": "randomised trials",
        "Risk of bias": ["serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["serious", "b"],
        "Other considerations": "none",
        "Nº of patients": {
            "Switch to TNFi": "53",
            "Switch to JAKi": "49"
        },
        "Effect": {
            "Relative (95% CI)": "-",
            "Absolute (95% CI)": "MD 9.91 higher (8.64 higher to 11.18 higher)"
        },
        "Certainty": "⨁⨁◯◯ LOW",
        "Importance": "IMPORTANT"
    }
}